Published in Am J Pathol on April 01, 1999
Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol (2001) 1.35
Differential regulation of interferon regulatory factor (IRF)-7 and IRF-9 gene expression in the central nervous system during viral infection. J Virol (2005) 1.15
STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc Natl Acad Sci U S A (2002) 1.02
Chemokine gene expression in astrocytes of Borna disease virus-infected rats and mice in the absence of inflammation. J Virol (2000) 1.00
Involvement of tissue plasminogen activator in onset and effector phases of experimental allergic encephalomyelitis. J Neurosci (2002) 0.98
Identification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis. Arthritis Res Ther (2006) 0.95
Role of CC chemokine CCL6/C10 as a monocyte chemoattractant in a murine acute peritonitis. Mediators Inflamm (2004) 0.87
Unaltered neurological disease and mortality in CXCR3-deficient mice infected intracranially with lymphocytic choriomeningitis virus-Armstrong. Viral Immunol (2008) 0.85
The "window of susceptibility" for inflammation in the immature central nervous system is characterized by a leaky blood-brain barrier and the local expression of inflammatory chemokines. Neurobiol Dis (2009) 0.82
Changes in gene expression of pial vessels of the blood brain barrier during murine neurocysticercosis. PLoS Negl Trop Dis (2013) 0.80
The role of macrophage class a scavenger receptors in a laser-induced murine choroidal neovascularization model. Invest Ophthalmol Vis Sci (2013) 0.79
Differential host gene responses from infection with neurovirulent and partially-neurovirulent strains of Venezuelan equine encephalitis virus. BMC Infect Dis (2017) 0.75
The Gut Epithelial Receptor LRRC19 Promotes the Recruitment of Immune Cells and Gut Inflammation. Cell Rep (2016) 0.75
Acute effects of focused ultrasound-induced increases in blood-brain barrier permeability on rat microvascular transcriptome. Sci Rep (2017) 0.75
A new class of membrane-bound chemokine with a CX3C motif. Nature (1997) 7.87
Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature (1990) 7.15
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med (1993) 4.94
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature (1997) 3.74
A simple, rapid method for the purification of poly A+ RNA. Biotechniques (1988) 3.22
A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells. Eur J Immunol (1995) 3.14
Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol (1992) 3.07
Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A (1993) 2.79
Lymphotactin: a cytokine that represents a new class of chemokine. Science (1994) 2.74
Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J (1993) 2.69
An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis. J Immunol (1995) 2.52
Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol (1995) 2.47
Chemokine expression in murine experimental allergic encephalomyelitis. J Neuroimmunol (1995) 2.13
Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J Immunol (1994) 2.03
Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol (1998) 1.87
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol (1998) 1.83
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci (1995) 1.82
Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol (1997) 1.79
Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol (1996) 1.67
Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. J Immunol (1996) 1.52
Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A (1997) 1.46
Overriding the brain's intrinsic resistance to leukocyte recruitment with intraparenchymal injections of recombinant chemokines. Neuroscience (1996) 1.36
Cerebral expression of multiple cytokine genes in mice with lymphocytic choriomeningitis. J Immunol (1994) 1.26
Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain Behav Immun (1995) 1.26
Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. J Immunol (1993) 1.19
Differential and time-dependent expression of monocyte chemoattractant protein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol (1997) 1.14
Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes. J Clin Invest (1996) 1.13
Indictment of the microglia as the villain in multiple sclerosis. Neurology (1997) 1.08
Novel expression pattern of a new member of the MIP-1 family of cytokine-like genes. Cell Regul (1991) 1.00
Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry (1997) 1.00
Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J Leukoc Biol (1997) 0.99
Regulation and function of central nervous system chemokines. Int J Dev Neurosci (1995) 0.98
Molecular cloning of leukotactin-1: a novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J Immunol (1997) 0.97
A novel chemokine, macrophage inflammatory protein-related protein-2, inhibits colony formation of bone marrow myeloid progenitors. J Immunol (1995) 0.96
CD8+ myelin peptide-specific T cells can chemoattract CD4+ myelin peptide-specific T cells: importance of IFN-inducible protein 10. J Immunol (1998) 0.93
Molecular cloning and functional characterization of a novel member of the C-C chemokine family. J Immunol (1995) 0.93
Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest (1996) 0.92
MIP-1 gamma: molecular cloning, expression, and biological activities of a novel CC chemokine that is constitutively secreted in vivo. J Inflamm (1995) 0.91
Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. Eur J Biochem (1997) 0.91
Selective induction of the beta chemokine C10 by IL-4 in mouse macrophages. J Immunol (1994) 0.89
Chronic intrathecal infusion of phosphorothioate or phosphodiester antisense oligonucleotides against cytokine responsive gene-2/IP-10 in experimental allergic encephalomyelitis of lewis rat. J Pharmacol Exp Ther (1996) 0.89
Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci Lett (1993) 0.89
The chemokine C10: immunological and functional analysis of the sequence encoded by the novel second exon. Cytokine (1996) 0.85
RCA-I lectin histochemistry after trypsinisation enables the identification of microglial cells in thin paraffin sections of the mouse brain. J Neurosci Methods (1993) 0.80
Chemical characterization of a family of brain lipids that induce sleep. Science (1995) 2.69
Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46
Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci (1998) 2.32
Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci (2000) 2.05
A central role for CD4(+) T cells and RANTES in virus-induced central nervous system inflammation and demyelination. J Virol (2000) 2.04
Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol (1998) 1.87
Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol (1998) 1.83
Chemokine gene expression in the brains of mice with lymphocytic choriomeningitis. J Virol (1997) 1.79
Chemokines in the CNS: plurifunctional mediators in diverse states. Trends Neurosci (1999) 1.73
Quantitative salivary gland scintigraphy in the diagnosis of parenchymal damage after treatment with radioiodine. Nucl Med Commun (1996) 1.67
Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum. Neuropathol Appl Neurobiol (2010) 1.65
Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am J Pathol (1998) 1.60
Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res (1983) 1.55
Coxsackievirus B3-induced myocarditis: perforin exacerbates disease, but plays no detectable role in virus clearance. Am J Pathol (1998) 1.46
Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci U S A (1997) 1.46
Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J Immunol (2001) 1.42
Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc Natl Acad Sci U S A (1995) 1.37
Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol (2001) 1.35
Borna disease virus-induced neurological disorder in mice: infection of neonates results in immunopathology. J Virol (1998) 1.35
DNA immunization with minigenes: low frequency of memory cytotoxic T lymphocytes and inefficient antiviral protection are rectified by ubiquitination. J Virol (1998) 1.34
Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol (1999) 1.31
Oleamide: an endogenous sleep-inducing lipid and prototypical member of a new class of biological signaling molecules. Curr Pharm Des (1998) 1.28
Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res (1999) 1.28
Gliosarcoma: a clinical study. Radiother Oncol (2001) 1.27
Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes. Br J Cancer (2009) 1.25
Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol (1995) 1.24
Neurological abnormalities associated with feline immunodeficiency virus infection. J Gen Virol (1994) 1.23
Transcripts encoding a neural membrane CD26 peptidase-like protein are stimulated by synaptic activity. Brain Res Mol Brain Res (1994) 1.22
Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys (1995) 1.20
A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature (1996) 1.19
Differential sensitivity of c-Fos expression in hippocampus and other brain regions to moderate and low doses of alcohol. Mol Psychiatry (1997) 1.17
Microglia stimulate naive T-cell differentiation without stimulating T-cell proliferation. J Neurosci Res (1999) 1.16
Reactive gliosis as a consequence of interleukin-6 expression in the brain: studies in transgenic mice. Dev Neurosci (1994) 1.16
Alpha/beta interferon promotes transcription and inhibits replication of borna disease virus in persistently infected cells. J Virol (2001) 1.14
Cerebrodiene: a brain lipid isolated from sleep-deprived cats. Proc Natl Acad Sci U S A (1994) 1.14
Systemic interferon-alpha regulates interferon-stimulated genes in the central nervous system. Mol Psychiatry (2007) 1.12
Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology (1986) 1.11
Effect of oleamide on sleep and its relationship to blood pressure, body temperature, and locomotor activity in rats. Exp Neurol (2001) 1.11
Adaptive responses of gamma-aminobutyric acid neurons in the ventral tegmental area to chronic ethanol. J Pharmacol Exp Ther (1999) 1.11
Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proc Natl Acad Sci U S A (1983) 1.09
T cell ignorance in mice to Borna disease virus can be overcome by peripheral expression of the viral nucleoprotein. Proc Natl Acad Sci U S A (1999) 1.08
Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest (2000) 1.07
Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. Am J Pathol (1998) 1.07
Responses of ventral tegmental area GABA neurons to brain stimulation reward. Brain Res (2001) 1.07
Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci Lett (1995) 1.06
Transgenic expression of TNF by astrocytes increases mechanical allodynia in a mouse neuropathy model. Neuroreport (2000) 1.06
Interferon-gamma enhances the expression of the major histocompatibility class I antigens on mouse pancreatic beta cells. Diabetes (1985) 1.06
Discharge profiles of ventral tegmental area GABA neurons during movement, anesthesia, and the sleep-wake cycle. J Neurosci (2001) 1.05
Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis. J Virol (1994) 1.05
Chemokines and the inflammatory response to viral infection in the central nervous system with a focus on lymphocytic choriomeningitis virus. J Neurovirol (1999) 1.04
Combined stent implantation and embolization with liquid 2-polyhydroxyethyl methacrylate for treatment of experimental canine wide-necked aneurysms. Neuroradiology (2002) 1.03
Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J Immunol (1997) 1.02
Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system. J Immunol (2000) 1.02
Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res (1988) 1.02
Early physiological abnormalities after simian immunodeficiency virus infection. Proc Natl Acad Sci U S A (1998) 1.01
Chemokine gene expression in astrocytes of Borna disease virus-infected rats and mice in the absence of inflammation. J Virol (2000) 1.00
Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry (1997) 1.00
Astrocyte-targeted expression of IL-12 induces active cellular immune responses in the central nervous system and modulates experimental allergic encephalomyelitis. J Immunol (2000) 1.00
Simian immunodeficiency virus: a model for neuroAIDS. Neurobiol Dis (1997) 0.99
Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature. J Neurooncol (2001) 0.99
Effects of adenosine, 2-deoxyadenosine and N6-phenylisopropyladenosine on rat islet function and metabolism. Biochem J (1982) 0.98
RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs. J Immunol Methods (1997) 0.98
Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys. J Med Primatol (1998) 0.98
Expression of nitric oxide synthase (NOS)-2 following permanent focal ischemia and the role of nitric oxide in infarct generation in male, female and NOS-2 gene-deficient mice. Brain Res (1999) 0.97
Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis. J Immunol (1999) 0.97
Characteristics of the release of adenosine 3':5'-monophosphate from micropipets by microiontophoresis. J Cyclic Nucleotide Res (1975) 0.97
Astrocyte-targeted expression of IFN-alpha1 protects mice from acute ocular herpes simplex virus type 1 infection. J Immunol (1998) 0.96
Ectopic expression of DNA encoding IFN-alpha 1 in the cornea protects mice from herpes simplex virus type 1-induced encephalitis. J Immunol (1999) 0.95
In vitro techniques for the assessment of neurotoxicity. Environ Health Perspect (1998) 0.95
Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. Proc Natl Acad Sci U S A (1994) 0.95
Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirol (1996) 0.95
Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc Natl Acad Sci U S A (1996) 0.95
Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin. Exp Dermatol (1997) 0.95
Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice. Curr Top Microbiol Immunol (2002) 0.93
Functional consequences of repeated (+/-)3,4-methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys. Neuropsychopharmacology (2001) 0.93
Opiate influences on nucleus accumbens neuronal electrophysiology: dopamine and non-dopamine mechanisms. J Neurosci (1989) 0.92
Overexpression of class I major histocompatibility complex accompanies insulitis in the non-obese diabetic mouse and is prevented by anti-interferon-gamma antibody. Diabetologia (1991) 0.92
Altered tissue distribution of viral replication and T cell spreading is pivotal in the protection against fatal lymphocytic choriomeningitis in mice after neutralization of IFN-alpha/beta. J Immunol (1994) 0.92
Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior. Oncogene (2011) 0.92
Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. J Clin Invest (1996) 0.92
The role of length of nerve exposed to local anesthetics in impulse blocking action. Anesth Analg (1989) 0.92
Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice. Am J Pathol (2000) 0.92
Chronic complement C3 gene expression in the CNS of transgenic mice with astrocyte-targeted interleukin-6 expression. Glia (1996) 0.91
Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression. J Virol (2001) 0.91
Inflammatory cytokines: putative regulators of neuronal and neuro-endocrine function. Brain Res Brain Res Rev (1998) 0.91
Cytokines: an expanding network of immuno-inflammatory hormones. Mol Endocrinol (1988) 0.91
Acute ethanol induces c-fos immunoreactivity in GABAergic neurons of the central nucleus of the amygdala. Brain Res (1998) 0.91
Cortistatin is expressed in a distinct subset of cortical interneurons. J Neurosci (1997) 0.91
Cytokine and chemokine production in HSV-1 latently infected trigeminal ganglion cell cultures: effects of hyperthermic stress. J Neuroimmunol (1998) 0.90
Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats. Brain Res (1994) 0.90
Reactivity to human islets and fetal pig proislets by peripheral blood mononuclear cells from subjects with preclinical and clinical insulin-dependent diabetes. Diabetes (1991) 0.90